论文部分内容阅读
目的：观察生长抑素治疗急性水肿型胰腺炎（AEP）的疗效，并进行费用分析。方法：将生长抑素类似物（善得定，善宁）或施他宁（生抑组）治疗22例AEP与用氟尿嘧啶（5－Fu）或加贝酯（非生抑组）治疗的18例AEP为对照组进行疗效观察及费用分析比较。结果：生抑组症状缓解，血、尿淀粉酶复常时间、住院天数均明显优于对照组（p＜0.05），但费用高出对照组60％～65％。若对照组住院费及中药费累加总费用也渐接近生抑组。结论：生抑组疗效明显优于非生抑组，但费用偏高，因而AEP不提倡过早使用生长抑素或其类似物，但病情较重或希望尽快缓解症状，缩短疗程者仍应考虑选用。
Objective: To observe the efficacy of somatostatin in the treatment of acute edematous pancreatitis (AEP) and to conduct cost analysis. METHODS: Twenty-two AEP patients treated with somatostatin analogues (Good Good, Good Nin) or Shitangning (5-Fu) or gabexate Cases AEP for the control group to observe the effect and cost analysis and comparison. Results: The symptom relief in Shengsutang group was better than those in control group (p <0.05), but the costs were 60% -65% higher than those in control group. If the control group of hospitalization costs and the total cost of traditional Chinese medicine is also gradually close to the students group. Conclusions: The efficacy of Shengyitiao is better than that of non-Shengyitiao, but the cost is high, so AEP does not advocate the premature use of somatostatin or its analogues, but the condition is serious or hope to relieve the symptoms as soon as possible, and shorten the course of treatment should still consider Use.